• Home >
  • Advances in Oncolytic Immunotherapy

Advances in Oncolytic Immunotherapy

22-Dec-2017  /  Research Code: D758-00-66-00-00  /  SKU: HC02946-GL-TA_21325  /  
Region: Global

USD 250.00

* Required Fields

USD 250.00

PAY BY INVOICE

Be the first to review this product

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across oncolytic immunotherapy. Next generation oncoloytic viral therapies, reovirus platforms, and cancer management strategies are depicted. The corresponding clinical trials scenario is illustrated, along with the industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics techno

Table of Contents

Advances in Oncolytic ImmunotherapyInnovations in Oncolytic ImmunotherapyNext-generation Oncolytic Viral Company Announces Senior Leadership AppointmentLeveraging Coxsackievirus for Oncolytic ImmunotherapyNovel Reovirus Platform for Cancer ManagementPsiOxus Therapeutics to Receive Milestone Payment from Bristol-Myers Squibb Clinical Trial Analysis and Industry InteractionsClinical Pipeline for ViralyticsSummary of Key Contacts




Related Research

PCHA and Partners HealthCare Connected Health Conference, 2018

Release Date : 21-Nov-18

Region : North America

Innovations in Medical Device Cybersecurity Solutions, ECG Monitoring, Artificial Chordae Delivery Systems, Implantable Pulse Generators, Mobile Health Platforms, Teleconsultation Services, and Laser Endomicroscopy

Release Date : 16-Nov-18

Region : Global

Companion Diagnostics: Biomarker Platforms Enabling Precision Medicine

Release Date : 13-Nov-18

Region : Global

Artificial Intelligence Revolutionizing the Pharmaceutical Industry

Release Date : 13-Nov-18

Region : Global

Innovations Involving Use of Quantum Dots in Life Science, Advanced Drug Discovery Platforms, and AAV-vector Manufacturing

Release Date : 09-Nov-18

Region : Global

Innovations in Defibrillators, Disinfection Systems, Orthopedic Implant Designing System, Alzheimer’s Detection, Breast Cancer Diagnosis, and Drug-eluting Stents

Release Date : 19-Oct-18

Region : Global

Unveiling the Potential of Novel Life Sciences Platforms in Stem Cells, Microbiome, Computational Genomics, and Advanced Diagnostics

Release Date : 12-Oct-18

Region : Global

Technology Growth Series--Market Trends and Emerging Opportunities for Visualization

Release Date : 29-Sep-18

Region : Global

Digital Innovations Creating an Immersive Environment for Health Monitoring

Release Date : 28-Sep-18

Region : Global

Innovations in AR-based Surgical Imaging, Mobile X-ray, Rapid Diagnostic Tests, and Image-guided Radiation Therapy

Release Date : 28-Sep-18

Region : Global

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.